phosphatidylcholines has been researched along with Hyperlipoproteinemia Type II in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (56.25) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cenarro, A; Civeira, F; Cofán, M; Mateo-Gallego, R; Ros, E; Sala-Vila, A | 1 |
| Aldover-Macasaet, E; Belgacem, O; Bicker, W; Bochkov, V; Pock, K; Sobal, G; Stübiger, G; Widhalm, K; Willfort-Ehringer, A | 1 |
| Illingworth, DR; Sundberg, EE | 1 |
| Greten, H; Raetzer, H; Schettler, G; Stiehl, A | 1 |
| Bräutigam, C; Duhm, J; Engelmann, B; Kulschar, R; Richter, WO; Thiery, J | 1 |
| Franceschini, G; Gianfranceschi, G; Lovati, MR; Manzoni, C; Michelagnoli, S; Pazzucconi, F; Sirtori, CR; Vecchio, G | 1 |
| Fong, K; He, JL; Hsia, SL; Milikowski, C; Nie, Y | 1 |
| Gundermann, KJ; Klimov, AN; Konstantinov, VO; Kuznetsov, AS; Lipovetsky, BM; Lozovsky, VT; Plavinsky, SL; Schumacher, R; Trufanov, VF | 1 |
| Hayasaka, K; Kinoshita, M; Miyazawa, T; Nagashima, T; Oikawa, S; Sekikawa, A; Toyota, T | 1 |
| Bogatskaia, LN; Korkushko, OV; Kotko, DN; Kovalenko, AN; Novikova, SN | 1 |
| Jover, E; López, IM; Rodriguez, F | 1 |
| Göpfert, E; Heuck, CC; Horsch, AK; Majolk, I | 1 |
| Abbate, R; Gensini, GF; Matucci, M; Neri Serneri, GG; Paniccia, R; Prisco, D; Rogasi, PG | 1 |
| Aviram, M; Brook, JG; Linn, S | 1 |
| Cattin, L; Da Col, PG; Descovich, GC; Gaddi, A; Gatti, E; Mannarino, E; Senin, U; Sirtori, CR; Sirtori, M; Zucchi-Dentone, C | 1 |
| Gensini, GF; Matucci, M; Neri Serneri, GG; Prisco, D; Rogasi, PG | 1 |
2 trial(s) available for phosphatidylcholines and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
[Effects of polyenylphosphatidylcholine (PPC) on serum lipids in patients with hyperlipoproteinemia. A double-blind study].
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Male; Middle Aged; Phosphatidylcholines | 1986 |
Effect of oral treatment with pantethine on platelet and plasma phospholipids in IIa hyperlipoproteinemia.
Topics: Administration, Oral; Adult; Aged; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Fatty Acids; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Pantetheine; Phosphatidylcholines; Phospholipids; Sphingomyelins; Sulfhydryl Compounds | 1987 |
14 other study(ies) available for phosphatidylcholines and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Eicosapentaenoic acid in serum phospholipids relates to a less atherogenic lipoprotein profile in subjects with familial hypercholesterolemia.
Topics: Adult; Alcohol Drinking; Animals; Atherosclerosis; Biomarkers; Cross-Sectional Studies; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fasting; Female; Fishes; Humans; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphatidylcholines; Phospholipids; Risk Factors; Surveys and Questionnaires; Triglycerides | 2013 |
Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS/MS.
Topics: Adolescent; Atherosclerosis; Biomarkers; Child; Cholesterol, LDL; Female; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Lipoproteins; Lysophosphatidylcholines; Male; Phosphatidylcholines; Phospholipids; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sphingomyelins; Tandem Mass Spectrometry; Young Adult | 2012 |
Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
Topics: Cholesterol; Colestipol; Heterozygote; Homeostasis; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neutrophils; Nicotinic Acids; Phosphatidylcholines; Polyamines; Reference Values | 1983 |
The effect of polyunsaturated phosphatidylcholine on plasma lipids and fecal sterol excretion.
Topics: Adolescent; Adult; Arteriosclerosis; Bile; Bile Acids and Salts; Child; Cholesterol; Feces; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Middle Aged; Phosphatidylcholines; Phospholipids; Sterols | 1980 |
Fast transmission of alterations in plasma phosphatidylcholine/sphingomyelin ratio and lyso phosphatidylcholine levels into changes of red blood cell membrane phospholipid composition after low density lipoprotein apheresis.
Topics: Blood Component Removal; Case-Control Studies; Cholesterol; Erythrocyte Membrane; Female; Heparin; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Middle Aged; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Sphingomyelins | 1995 |
Effect of gemfibrozil treatment in hypercholesterolemia on low density lipoprotein (LDL) subclass distribution and LDL-cell interaction.
Topics: Adult; Aged; Analysis of Variance; Apolipoproteins; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Female; Fibroblasts; Gemfibrozil; Glycoproteins; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Middle Aged; Phosphatidylcholines; Receptors, LDL; Sterol O-Acyltransferase; Triglycerides | 1995 |
The hypocholesterolemic and antiatherogenic effects of topically applied phosphatidylcholine in rabbits with heritable hypercholesterolemia.
Topics: Administration, Cutaneous; Animals; Anticholesteremic Agents; Aorta, Thoracic; Arteriosclerosis; Cholesterol; Cholesterol, LDL; Choline; Disease Models, Animal; Hyperlipoproteinemia Type II; Inbreeding; Phosphatidylcholines; Phospholipids; Rabbits | 1996 |
"Essential" phospholipids versus nicotinic acid in the treatment of patients with type IIb hyperlipoproteinemia and ischemic heart disease.
Topics: Cholesterol, HDL; Cholesterol, LDL; Fat Emulsions, Intravenous; Female; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Myocardial Ischemia; Niacin; Phosphatidylcholines | 1995 |
Age-related increases in plasma phosphatidylcholine hydroperoxide concentrations in control subjects and patients with hyperlipidemia.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Male; Middle Aged; Phosphatidylcholines | 2000 |
[Correction of dyslipoproteinemia in middle-aged and elderly patients with atherosclerosis using Essentiale in combination with adebit].
Topics: Aged; Aged, 80 and over; Biguanides; Buformin; Coronary Artery Disease; Drug Evaluation; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Middle Aged; Phosphatidylcholines; Tablets; Time Factors | 1989 |
Plafibride treatment and serum lipids in hyperlipoproteinemias.
Topics: Adolescent; Adult; Blood Glucose; Cholesterol; Clofibrate; Clofibric Acid; Diet; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Insulin; Male; Phosphatidylcholines; Triglycerides | 1987 |
Dietary soya lecithin decreases plasma triglyceride levels and inhibits collagen- and ADP-induced platelet aggregation.
Topics: Adenosine Diphosphate; Adult; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Collagen; Diet; Glycine max; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Middle Aged; Phosphatidylcholines; Platelet Aggregation; Triglycerides | 1986 |
Cholesterol-lowering and HDL-raising properties of lecithinated soy proteins in type II hyperlipidemic patients.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Female; Glycine max; Humans; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Male; Middle Aged; Phosphatidylcholines; Plant Proteins, Dietary; Soybean Proteins; Triglycerides | 1985 |
Changes in fatty acid composition of the single platelet phospholipids induced by pantethine treatment.
Topics: Administration, Oral; Adult; Aged; Blood Platelets; Cholesterol; Cholesterol, HDL; Chromatography, Gas; Fatty Acids; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Male; Middle Aged; Pantetheine; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Sulfhydryl Compounds; Triglycerides | 1985 |